Cellective Therapeutics

Cellective Therapeutics, Inc.: A drug development company dedicated to the discovery, development, and commercialization of monoclonal antibodies for the treatment of B-cell cancers and autoimmune diseases. Its product pipeline includes monoclonal antibodies targeting B-cell antigens CD19, CD20, and CD22, which are in the preclinical stage.